Problem drugs for the patient with asthma

Comprehensive Therapy

Volumn 22, Issue 6, 1996, Pages 339-344

  Craig, Timothy ^a   Richerson, Hal B ^b   Moeckli, Jane ^b  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; BARBITURIC ACID DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAMAZEPINE; CIMETIDINE; CIPROFLOXACIN; CONTRAST MEDIUM; DICLOFENAC; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FENOPROFEN; FLURBIPROFEN; FUROSEMIDE; IBUPROFEN; INDOMETACIN; ISONIAZID; KETOPROFEN; KETOROLAC; MEFENAMIC ACID; METHOTREXATE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PIROXICAM; SULINDAC; THEOPHYLLINE; TOLMETIN; UNINDEXED DRUG; ZOMEPIRAC;

ARACHIDONIC ACID METABOLISM; ASTHMA; DRUG EFFECT; DRUG HYPERSENSITIVITY; ENZYME INHIBITION; HUMAN; HYPERTENSION; PROSTAGLANDIN SYNTHESIS; REVIEW;

ADRENERGIC BETA-ANTAGONISTS; ANAPHYLAXIS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASTHMA; BRONCHODILATOR AGENTS; CONTRAST MEDIA; DRUG INTERACTIONS; HISTAMINE H1 ANTAGONISTS; HUMANS; THEOPHYLLINE;

EID: 0030057097     PISSN: 00988243     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Hunt LW. Asthma-producing drugs. Ann Allergy. 1992;68:453-462.
2. Dahlen B, Kumlin M, Margolskee DJ, et al. The leukotriene-receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics. Eur Resp J. 1993;6:1018-1026.
3. Sweet JM, Stevenson DD, Simon RA, et al. Long term effects of aspirin desensitization: treatment for aspirin-sensitive rhinosinusitis-asthma. J Allergy Clin Immunol. 1990;85:59-65.
4. Herbert WG, Scopelitis E. Ketorolac-precipitated asthma. South Med J. 1994;87:282-283.
5. Settipane RA, Stevenson DD. Cross sensitivity with acetaminophen in aspirin-sensitive subjects with asthma. J Allergy Clin Immunol. 1988;84:26-33.
6. Szczeklik A, Nizankowska E, Dworski R. Choline magnesium trisalicylate in patients with aspirin induced asthma. Eur Respir J. 1990;3:535-539.
7. Nizankowska E, Dworski R, Soja J, et al. Salicylate pre-treatment attenuates intensity of bronchial and nasal symptoms precipitated by aspirin in aspirin-intolerant patients. Clin Exp Allergy. 1990;20:647-652.
8. Stevenson D. Diagnosis, prevention, and treatment of adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs. J Allergy Clin Immunol. 1984;74:617-622.
9. Graft DF, Fowles J, McCoy CE, et al. Detection of beta-blocker use in people with asthma. Ann Allergy. 1992;69:449-453.
10. Lunde H, Hedner T, Samuelsson O, et al. Dyspnea, asthma, and bronchospasm in relation to treatment with angiotensin converting enzyme inhibitors. Brit Med J. 1994;308:18-21.
11. Kaufman J, Schmitt S, Barnard J, et al. Angiotensin converting enzyme inhibitors in patients with bronchial responsiveness and asthma. Chest 1992;101:922-925.
12. Hargreaves MR, Benson MK. Inhaled sodium cromoglycate in angiotensin converting enzyme inhibitor cough. Lancet. 1995;345:13-16.
13. Slater EE, Merrill DD, Guess HA, et al. Clinical profile of angioedema associated with angiotensin converting enzyme inhibitor. JAMA. 1988;260:967-970.
14. Abramowicz M. Losartan for hypertension. The Medical Letter. 1995;37:57-58.
15. Lang DM, Alpern MB, Visintainer PF, et al. Elevated risk of anaphylactoid reaction from radiographic contrast media is associated with both beta-blocker exposure and cardiovascular disorders. Arch Intern Med. 1993;153:2033-2040.
16. Greenberger PA, Halwig TM, Patterson R, et al. Emergency administration of a radiocontrast media in high risk patients. J Allergy Clin Immunol. 1986;77:630-634.
17. Masheter HC. Terfenadine: the first non-sedating antihistamine. Clin Rev Allergy. 1993;11:5-34.
18. Peck CC, Temple R, Collins JM. Understanding consequences of concurrent therapies. JAMA. 1993;269:1550-1552.
19. Honig PK, Wortham DC, Zamani K, et al. Effect of erythromycin, clarithromycin, and azithromycin on the pharmacokinetics of terfenadine. Clin Pharmacol Ther. 1993;53:161. Abstract PI-106.
20. Klausner MA. New safety information regarding propulsid (cisapride). Titusville, NJ: Janssen warning. 1995
21. Honig PK, Wortham DC, Zamani K, et al. Effect of concomitant administration of cimetidine and ranitidine on the pharmacokinetics and electrocardiographic effects of terfenadine. Eur J Clin Pharmacol. 1993;45:41-46.